(Q57291492)

English

TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe

No description defined

Statements

TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
K. Szymańska
0 references
L.E. Moore
0 references
W.H. Chow
0 references
F. Waldman
0 references
E. Jaeger
0 references
T. Waterboer
0 references
L. Foretova
0 references
M. Navratilova
0 references
H. Kollarova
0 references
V. Matveev
0 references
D. Mates
0 references
F. Le Calvez-Kelm
0 references
S. Villar
0 references
P. Brennan
0 references
July 2010
0 references
293
0 references
1
0 references
92-98
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit